CIK: 0001795594 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 10, 2021
Total Value ($000): $162 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| DOCS | DOXIMITY INC | 2,500 | $146 | 90.1% | $56.14 | 0.0% | CL A | 26622P107 |
| — | LYELL IMMUNOPHARMA INC | 1,000 | $16 | 9.9% | $16.00 | — | COM | 55083R104 |